Annual report pursuant to Section 13 and 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v3.10.0.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member]
Jan. 02, 2019
USD ($)
Ownership allocation after merger of Company's common stock 20.00%
Percent increase (decrease) in ownership allocation for excess proceeds (0.10%)
NeuBaseTherapuetics, Inc.  
Ownership allocation after merger of Company's common stock 80.00%
Percent increase (decrease) in ownership allocation for excess proceeds 0.10%
Termination fee of merger agreement $ 250,000
NeuBaseTherapuetics, Inc. | Dr. Jason Slakter [Member]  
Retention bonus amount 75,000
NeuBaseTherapuetics, Inc. | Minimum [Member]  
Amount of entity's equity securities to be issued or sold prior to merger 4,000,000
Excess proceeds of minimum amount of equity securities to be issued or sold prior to merger $ 100,000